Study Summary
This trial is looking at whether abatacept is effective for treating granulomatous-lymphocytic interstitial lung disease in people with common variable immunodeficiency.
- Common Variable Immunodeficiency
- Interstitial Lung Disease
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 18 Secondary · Reporting Duration: 6months, 12 months
Trial Safety
Safety Progress
Side Effects for
Trial Design
2 Treatment Groups
Abatacept
1 of 2
Placebo
1 of 2
Experimental Treatment
Non-Treatment Group
60 Total Participants · 2 Treatment Groups
Primary Treatment: Abatacept · Has Placebo Group · Phase 2
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age Any Age · All Participants · 13 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Are there any dangers associated with Abatacept?
"There is some data supporting the safety of Abatacept, but none yet for efficacy. We've given it a score of 2." - Anonymous Online Contributor
What are some of the most popular reasons that doctors prescribe Abatacept?
"Abatacept is a medication prescribed to patients with [rheumatoid arthritis](https://www.withpower.com/clinical-trials/rheumatoid-arthritis). It's also used to mitigate the symptoms of psoriatic arthritis, polyarticular juvenile idiopathic arthritis, and severe juvenile idiopathic arthritis." - Anonymous Online Contributor
Are there still places available for people who want to participate in this research?
"Yes, as of 9/9/2022 this trial is still looking for participants. The listing was created on 7/14/2021." - Anonymous Online Contributor
Are there any other similar cases in which Abatacept has been used?
"Currently, there are 36 ongoing studies investigating abatacept. 8 of those trials have reached Phase 3 clinical testing. The majority of these investigations into abatacept's efficacy are taking place in Toronto, but there are a total of 772 research sites worldwide." - Anonymous Online Contributor
How many people are signing up to be a part of this test group?
"Yes, as specified on clinicaltrials.gov, this study is recruiting patients. The trial was posted on 7/14/2021 and updated on 9/9/2022. They are looking for 60 participants from 1 site." - Anonymous Online Contributor